DaVita Inc. (DVA) News
Follow DaVita Inc. (DVA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 28 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
DaVita Reports Quarterly Results for Period Ended September 30
A machine-generated LSEG earnings summary covers DaVita’s quarter ended September 30.
EQUITY | Oct 29, 2026, 10:31 PM UTC
M
DaVita raises lower end of 2026 profit forecast; shares fall
DaVita shares fell in after-hours trading after the company raised the lower end of its 2026 profit forecast.
EARNINGS | Oct 29, 2026, 10:07 PM UTC
M
DaVita Raises 2026 Profit Guidance Floor; Shares Fall
DaVita raised the lower end of its 2026 profit forecast, while its shares fell.
EARNINGS | Oct 29, 2026, 10:07 PM UTC
M
DaVita lifts lower end of 2026 profit forecast; shares fall 7.4%
DaVita raised the lower end of its 2026 profit forecast. Its shares fell 7.4%.
EARNINGS | Oct 29, 2026, 10:07 PM UTC
M
DaVita Repurchased 382,563 Shares From Berkshire Hathaway
SEC filings show Berkshire Hathaway still owned about 28.3 million DaVita shares following the repurchase.
EQUITY | Oct 29, 2026, 09:45 PM UTC
M
DaVita Reports Third-Quarter 2026 Revenue of $3.58 Billion
Revenue rose 4.6% year over year to $3.58 billion. Net income attributable to DaVita increased 48.3% to $222.93 million, while diluted EPS rose 66.7% to $3.40.
EQUITY | Oct 29, 2026, 09:11 PM UTC
M
DaVita Q3 Revenue Beats Analyst Estimates on Higher Reimbursement Rates
EQUITY | Oct 29, 2026, 08:20 PM UTC
M
DaVita Reports Third-Quarter Revenue of $3.58B
EQUITY | Oct 29, 2026, 08:12 PM UTC
M
DaVita reports third-quarter 2026 financial and operating results
DaVita said it announced results for the quarter ended September 30, 2026. The supplied body excerpt lists U.S. dialysis metrics but is truncated before providing figures.
EQUITY | Oct 29, 2026, 08:06 PM UTC
M
DaVita Reports Third-Quarter Net Income of $222.9 Million
EARNINGS | Oct 29, 2026, 08:06 PM UTC
M
DaVita Reports Third-Quarter Adjusted EPS of $3.82
EARNINGS | Oct 29, 2026, 08:06 PM UTC
M
DaVita Sees FY Adjusted EPS of $14.30-$15.20
EARNINGS | Oct 29, 2026, 08:06 PM UTC
M
DaVita Shares Fall 7.1% After Report of New Kidney Care Plan
DaVita shares fell 7.1% in afternoon trading after Axios reported that the Department of Health and Human Services released a new kidney care plan from the Trump administration. The report’s description of the initiative
EQUITY | Oct 20, 2026, 09:17 PM UTC
M
DaVita Q3 Results Expected October 23
DaVita is set to report Q3'26 results on October 23. Revenue and EPS estimates were provided; the release time is not specified.
EQUITY | Oct 16, 2026, 11:00 AM UTC
L
Undervalued healthcare stocks with attractive valuation grades
Healthcare stocks continue to attract investor attention as managed care providers, pharmaceutical companies, biotechnology firms and healthcare services businesses navigate changing demand and industry conditions.With v
NEWS | Sep 15, 2026, 05:21 PM UTC
L
Ten healthcare stocks with A-rated valuations and strong revenue growth
Healthcare stocks remain a focal point for investors as pharmaceutical innovation, biotechnology advancements, and managed care expansion continue to drive growth across the sector.While many healthcare companies trade a
EQUITY | Sep 09, 2026, 03:01 PM UTC
L
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025
NORTHAMPTON, MA / / September 8, 2026 / DaVita's care network reaches people in every corner of the U.S. as well as 14 countries around the world. In every community the comprehensive kidney care provider touches, DaVita
EQUITY | Sep 08, 2026, 01:35 PM UTC
L
DaVita Community Care Report 2025: Leading With Integrity and Accountability
NORTHAMPTON, MA / / September 4, 2026 / At DaVita, doing the right thing and conducting business activities with the highest standards of ethics is foundational to our culture. We are firmly committed to compliance with
EQUITY | Sep 04, 2026, 04:20 PM UTC
L
DVA - Alebund Pharmaceuticals Announces 2026 Interim Results
DVA - Alebund Pharmaceuticals Announces 2026 Interim Results
EQUITY | Aug 26, 2026, 10:49 AM UTC
L
DaVita, Humana launch value-based CKD care partnership
DaVita says its integrated kidney care program launches July 1 with Humana Medicare Advantage to serve more than 10,000 patients with chronic kidney disease stages 3B-5.
EQUITY | Aug 25, 2026, 10:12 AM UTC
H
The Economy Lost Jobs, Wall Street Threw a Party: What Moved Markets This Week
The American economy shed 23,000 nonfarm payrolls in July. Wall Street answered with its best week since April. That is not a contradiction. It turns on the fact that has defined 2026 and that many investors still find u
EARNINGS | Aug 07, 2026, 07:40 PM UTC
H
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
Gold ripped 4% higher to $4,233.89 an ounce on Wednesday, its biggest one-day advance since February, as a soft private payrolls report and easing energy costs knocked down the odds of another Federal Reserve rate hike.
EARNINGS | Aug 05, 2026, 06:14 PM UTC
H
SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Wednesday. Shares of Space Exploration Technologies Corp (NASDAQ: SPCX ) fell sharply in pre-market trading after the company
EARNINGS | Aug 05, 2026, 12:03 PM UTC
H
DaVita Affirms FY2026 Adj EPS Guidance of $14.10-$15.20 vs $14.82 Est
DaVita (NYSE: DVA ) affirms FY2026 Adj EPS guidance from $14.10-$15.20 to $14.10-$15.20 vs $14.82 analyst estimate..
EARNINGS | Aug 04, 2026, 08:07 PM UTC
L
DVA - DaVita Inc. 2nd Quarter 2026 Results
DVA - DaVita Inc. 2nd Quarter 2026 Results
EQUITY | Aug 04, 2026, 08:05 PM UTC
H
DVA Hits Lows
DVA hits new lows
EQUITY | Jul 30, 2026, 07:36 PM UTC
L
DVA highs +2%
DVA highs +2%
EQUITY | Jul 17, 2026, 02:44 PM UTC
L
DaVita price target raised by $45 at Truist, here's why
DaVita price target raised by $45 at Truist, here's why
EQUITY | Jul 14, 2026, 11:50 AM UTC